PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 71 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $136,000 | +52.8% | 22,081 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | -77.1% | 19,100 | -74.5% | 0.00% | -66.7% |
| Q3 2014 | $389,000 | -30.5% | 75,000 | -42.3% | 0.00% | -40.0% |
| Q2 2014 | $560,000 | -32.6% | 130,000 | -16.6% | 0.01% | 0.0% |
| Q4 2013 | $831,000 | +372.2% | 155,900 | +345.4% | 0.01% | +150.0% |
| Q3 2013 | $176,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |